Global Rare Biomarkers Specimen Collection And Stabilization Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Rare Biomarkers Specimen Collection And Stabilization Market During The Forecast Period 2026–2030?
The rare biomarkers specimen collection and stabilization market size has experienced rapid growth in recent years. It is anticipated to increase from $35.29 billion in 2025 to $38.94 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.3%. The historical expansion of this market is attributable to developments such as the growth in molecular diagnostics research, the expansion of oncology biomarker studies, the availability of plasma-based testing methods, increasing clinical trial activity, and the rising use of biobanking practices.
The rare biomarkers specimen collection and stabilization market is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $55.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period is primarily attributable to factors such as the wider uptake of precision diagnostics, a surging need for early disease identification, the expansion of genomic and transcriptomic testing methodologies, increasing financial commitments to biomarker-driven drug development, and the growing incorporation of AI into biomarker analysis. Furthermore, key trends shaping the market over this period encompass the increasing integration of liquid biopsy collection methods, the expanded utilization of sophisticated stabilization reagents, a heightened requirement for preserving high-sensitivity biomarkers, the broadening scope of non-invasive diagnostic applications, and a reinforced emphasis on the integrity and traceability of samples.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15913&type=smp
Which Major Factors Are Driving The Expansion Of The Rare Biomarkers Specimen Collection And Stabilization Market?
The market for rare biomarker specimen collection and stabilization is anticipated to expand due to the rising occurrence of cancer. Cancer encompasses a wide range of illnesses marked by the unrestrained proliferation and dissemination of abnormal cells. This surge in cancer cases stems from elements like environmental factors, lifestyle choices such as smoking and an unhealthy diet, and inherent genetic predispositions, collectively creating a greater demand for accurate diagnostic and monitoring instruments. The crucial function of rare biomarker specimen collection and stabilization involves ensuring the precise preservation of blood- and tissue-derived biomarkers, essential for initial diagnosis, molecular characterization, and choosing appropriate therapies in cancer treatment. For example, in February 2024, the World Health Organization, an intergovernmental body based in Switzerland, forecast more than 35 million new cancer cases by 2050. This figure signifies a 77% rise from the approximately 20 million cases estimated in 2022. Consequently, the growing incidence of cancer is a key factor propelling the expansion of the rare biomarker specimen collection and stabilization market.
What Market Segments Are Evaluated Within The Rare Biomarkers Specimen Collection And Stabilization Market?
The rare biomarkers specimen collection and stabilization market covered in this report is segmented –
1) By Type: Circulating Cell Free Deoxyribonucleic Acid (CCFDNA), Circulating Tumor Cells (CTCs), Exosomes or Extracellular Vesicles
2) By Specimen: Serum Or Plasma, Other Specimens
3) By Application: Non-Invasive Prenatal Testing (NIPT), Oncology, Transcriptomics, Pharmacogenomics, Transplant Rejection, Population Screening, Cardiovascular Diseases, Other Applications
4) By End-User: Hospitals, Perinatal Clinics, Public Health Labs, Private Or Commercial Labs, Physician Labs, Research Institutes, Other End-Users
Subsegments:
1) By Circulating Cell Free Deoxyribonucleic Acid (CCFDNA): Plasma CCFDNA, Serum CCFDNA
2) By Circulating Tumor Cells (CTCs): CTCs In Blood, CTCs In Bone Marrow
3) By Exosomes Or Extracellular Vesicles: Exosomes From Plasma, Exosomes From Serum
What Trends Are Affecting The Expansion Of The Rare Biomarkers Specimen Collection And Stabilization Market?
Companies operating in the rare biomarkers specimen collection and stabilization market are increasingly concentrating on developing advanced solutions, such as automated plasma and cell sample preparation, to maintain biomarker integrity and enable high-throughput multiomics. These automated pre-analytical platforms refer to technologies that standardize the processing of blood samples, including plasma separation, cell fixation, and slide preparation, directly at the point of collection, ensuring consistent specimen quality without manual handling or specialized tubes. For instance, in April 2024, Tethis S.p.A., an Italy-based biotechnology company, announced the enrollment of the first two patients in a clinical study for its See.d platform. This platform automates standardized plasma and cell sample preparation for multiomic liquid biopsy, which involves the fixation of rare circulating tumor and immune cells on nanocoated SmartBioSurface slides. Designed to maximize sample integrity and facilitate seamless analysis of cell-free DNA and circulating tumor cells from a single draw, the platform effectively supports the entire end-to-end workflow of rare biomarker specimen collection and stabilization.
Who Are The Top Market Participants Influencing The Rare Biomarkers Specimen Collection And Stabilization Market?
Major companies operating in the rare biomarkers specimen collection and stabilization market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Miltenyi Biotec GmbH, Natera Inc., Promega Corporation, Myriad Genetics, Hamilton Company, OraSure Technologies Inc., Fluidigm Corporation, Streck Inc., SeraCare, Enzo Biochem Inc., Epigenomics AG, Veridex LLC
Read the full rare biomarkers specimen collection and stabilization market report here:
Which Region Currently Holds The Largest Share Of The Rare Biomarkers Specimen Collection And Stabilization Market?
North America was the largest region in the rare biomarkers specimen collection and stabilization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare biomarkers specimen collection and stabilization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Rare Biomarkers Specimen Collection And Stabilization Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15913&type=smp
Browse Through More Reports Similar to the Global Rare Biomarkers Specimen Collection And Stabilization Market 2026, By The Business Research Company
Blood Transfusion Diagnostics Global Market Report
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
Hematology Diagnostic Devices And Equipment Global Market Report
Immunochemistry Diagnostic Devices And Equipment Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
